This review found no evidence to suggest that supplementation of infant formula with long-chain polyunsaturated fatty acids affects the growth of term infants. Although the results provided support this, the limited literature search and poor reporting of review methodology make it difficult to verify this conclusion.
Authors' objectives
To assess the effect of supplementing infant formula with long-chain polyunsaturated fatty acids (LCPUFAs) on the growth of term infants.
Searching
MEDLINE was searched from 1960 to July 2004; the search terms are listed in the review. The bibliographies of retrieved papers and proceedings of relevant conferences were also searched. No mention of language restrictions was made.
Study selection

Study designs of evaluations included in the review
Randomised controlled trials (RCTs) were eligible for inclusion.
Specific interventions included in the review
The intervention was cow's milk-based infant formula supplemented with LCPUFAs. The LCPUFAs in the included interventions were docosahexaenoic acid and arachidonic acid from various sources, such as fish oils, egg phospholipid fractions, egg triacylglycerol fractions, and algal and fungal oils. The control group were given equivalent unsupplemented infant formula. Trials in which interventions were initiated within 14 days of birth and were given for at least 12 weeks were eligible for inclusion. The interventions in the included trials lasted for 3 to 12 months.
Participants included in the review
Trials of infants born at term (not defined) were eligible for inclusion.
Outcomes assessed in the review
Studies that reported data on infant growth were eligible for inclusion. Authors were contacted to obtain data on weight, length and head circumference. The included trials varied in the ages at which growth assessments were made, but most infants were assessed at 4 months.
How were decisions on the relevance of primary studies made?
